ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Allakos Inc

Allakos Inc (ALLK)

1.20
-0.09
(-6.98%)
Closed December 21 4:00PM
1.20
0.00
(0.00%)
After Hours: 6:56PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.20
Bid
1.05
Ask
2.40
Volume
474,457
1.21 Day's Range 1.38
0.535 52 Week Range 3.36
Market Cap
Previous Close
1.29
Open
1.28
Last Trade
29
@
1.23
Last Trade Time
Financial Volume
$ 621,992
VWAP
1.311
Average Volume (3m)
681,406
Shares Outstanding
89,343,634
Dividend Yield
-
PE Ratio
-0.58
Earnings Per Share (EPS)
-2.08
Revenue
-
Net Profit
-185.7M

About Allakos Inc

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Sig... Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Allakos Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALLK. The last closing price for Allakos was $1.29. Over the last year, Allakos shares have traded in a share price range of $ 0.535 to $ 3.36.

Allakos currently has 89,343,634 shares outstanding. The market capitalization of Allakos is $115.25 million. Allakos has a price to earnings ratio (PE ratio) of -0.58.

ALLK Latest News

Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm PR Newswire NEW YORK, Dec. 19, 2024 NEW YORK, Dec. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1312.14953271031.071.3414130361.16633022CS
40.333738.52014313750.86631.340.79623212361.08398898CS
120.612104.0816326530.5881.5550.5736814061.13649267CS
260.087.142857142861.121.5550.5356039640.99583083CS
52-1.74-59.18367346942.943.360.5358089631.27063919CS
156-80.29-98.527426678181.4984.93990.53513778565.35616165CS
260-107.71-98.8981728032108.91157.980.53593518115.51235021CS

ALLK - Frequently Asked Questions (FAQ)

What is the current Allakos share price?
The current share price of Allakos is $ 1.20
How many Allakos shares are in issue?
Allakos has 89,343,634 shares in issue
What is the market cap of Allakos?
The market capitalisation of Allakos is USD 115.25M
What is the 1 year trading range for Allakos share price?
Allakos has traded in the range of $ 0.535 to $ 3.36 during the past year
What is the PE ratio of Allakos?
The price to earnings ratio of Allakos is -0.58
What is the reporting currency for Allakos?
Allakos reports financial results in USD
What is the latest annual profit for Allakos?
The latest annual profit of Allakos is USD -185.7M
What is the registered address of Allakos?
The registered address for Allakos is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Allakos website address?
The website address for Allakos is www.allakos.com
Which industry sector does Allakos operate in?
Allakos operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.5M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.63M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.84M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
8.58M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
5.96M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
281.23M

ALLK Discussion

View Posts
glenn1919 glenn1919 2 months ago
ALLK.................................https://stockcharts.com/h-sc/ui?s=ALLK&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
wesley_ wesley_ 2 months ago
nice set up
πŸ‘οΈ0
Banjo50 Banjo50 3 months ago
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
ALLK 10Q due 3/19
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
ALLK under $2
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
ALLK 10Q due March 12
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
ALLK 10Q due March 5
πŸ‘οΈ0
glenn1919 glenn1919 10 months ago
ALLK..........................................................................https://stockcharts.com/h-sc/ui?s=ALLK&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
ALLK under $2
πŸ‘οΈ0
RobH1312 RobH1312 3 years ago
THIS POS IS A SCAM GONNA GO DOWN DOWN DOWN!!!

















imo
πŸ‘οΈ0
REAGAN REAGAN 3 years ago
We will go short on this one.
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Agree, the next couple weeks should be very interesting .
πŸ‘οΈ0
REAGAN REAGAN 3 years ago
The whole Nasdaq is crashing. A stock whose IP doesn’t work should be pulverized next week.
πŸ‘οΈ0
REAGAN REAGAN 3 years ago
Made it go down 95%. The technology doesn’t work….
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
It was a good flip, still looks attractive at this level, but I will wait .
πŸ‘οΈ0
REAGAN REAGAN 3 years ago
This aged well
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Allakos Inc. (the β€œCompany” or β€œAllakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today reported data from ENIGMA 2, a 24-week Phase 3 randomized, double-blind, placebo-controlled study of lirentelimab in patients with biopsy confirmed eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) and KRYPTOS, a 24-week Phase 2/3 randomized, double-blind, placebo-controlled study of lirentelimab in patients with biopsy-confirmed eosinophilic esophagitis (EoE). Both ENIGMA 2 and KRYPTOS studies met their histologic co-primary endpoints, but did not achieve statistical significance on the patient reported symptomatic co-primary endpoints.
β€œWe are deeply disappointed that the studies did not achieve their symptomatic endpoints,” said Robert Alexander, PhD, Chief Executive Officer of Allakos. β€œThe company is grateful to the patients with eosinophilic gastrointestinal diseases (EGIDs) and to the investigators who participated in the ENIGMA and KRYPTOS trials.”
πŸ‘οΈ0
REAGAN REAGAN 3 years ago
Zero squeeeze. What’s up with this company. How’d it lose 97% of value in one year?
πŸ‘οΈ0
REAGAN REAGAN 3 years ago
So what’s the deal with this stock? Why has the stock price fallen 97%? Where do you see the company has $500m cash on hand?
πŸ‘οΈ0
BullofLA BullofLA 3 years ago
Yup, total scam, run away.
πŸ‘οΈ0
Inves2day Inves2day 3 years ago
Allakos holders - please read and share the link below.


Stock wash sale 30 days period ended on 21 January 2022. December sellers will be looking to buy back now. Two after hours buys yesterday make more sense now.

ALLK is a forgotten share, but not for those who have to buy it back. The seller is gone for two days, but the sentiment is negative around all Nasdaq shares hence negative ends on Thu and Fr. This will change too.
I saw on Thursday 20 January that there was an appetite to climb up, really. Virtually no seller around. During the day all was going well, MMs were ticking it nicely higher until that moment of crash caused by Netflix followed by the entire Nasdaq falling down. Friday Nasdaq still down so ALLK too. But every crash ends and reversal starts for new buyers.

Look, as ALLK holders, we all can and have to create a need for shorters and those who sold in December for tax reasons to start the buy back. We need an bigger action to close day at 5-10% up to get noticed in media.
I. e. ADGI reversed exactly after 30 days wash sale. Allakos can do the same if we really want it.

Sell only if you really have to or Hold it for a few more days to see if recovery kicks in with Nasdaq stabilising.

Allakos Inc at $7 mcap is slightly lower than cash and equivalents.
We know they did not deliver but ffs share is down from $84 to $7 and they still be looking to use thst drug in another areas.

Please share the below post on Twitter for awareness.

https://twitter.com/inves2day/status/1485023226753437698?t=aK2TQngCviUwopFKMOEmjQ&s=19


Thank you for reading and sharing.

*23 Jan - my account on StockTwits has been suspended after posting the above link*
πŸ‘οΈ0
Banjo50 Banjo50 3 years ago
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
πŸ‘οΈ0
donwillems donwillems 3 years ago
well this has 3 stages for me, everything +9.50, allright
everything above 10+, superb
everything above 12.50, winner winner chicken dinner.

A company with 500 million up their sleeves, I think they might figure something out.

And whats more, why did I buy into this company?
I have EOE myself, it's being triggered by cow milk with me and my throat and stumach gets hurt really bad by the eosiphiniles If I don't watch out with avoiding everything with milk.

I'm totally wondered here how that however the drug significantly reducing the eosiphiniles in situ doesn't get a response on the symptons, this starts me wondering if the direct symptons only thrive by the (food)allergy people have with it.

For now, I avoid milk and use omeprazole to completly suppres the effects, corticosteriod can be used locally but they are bad for blood vessels long term.

To get to the point, I think this drug isn't wrote off at all, the eosiphiniles do damage the throat a lot long term in this disease, if left untreathed, the throat will start forming circular scars, making it smaller and making it long term impossible to get food into the stumach.

The research completly ignores this problem, while it's the second main cause for treating this disease, unimaginable if you ask me.
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Sure she’s trying to breakout !
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Squeeze !
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Dip and rip, short trying so hard !!
πŸ‘οΈ0
da_stock_analyst da_stock_analyst 3 years ago
Two Stocks to Watch: #NXTD ?? #ALLK ?? Should you buy now for the possible run-up? Technical analysis!
πŸ‘οΈ0
Huti Huti 3 years ago
20??? Maybe??? What do you guys think?
πŸ‘οΈ0
forgiveness7x7 forgiveness7x7 3 years ago
DD here Can someone Box/Sticky it
https://twitter.com/tryingBot05/status/1473861479309152257
https://twitter.com/RealTimeTradez/status/1473987872197914633/photo/1
https://twitter.com/SilentTrader93/status/1474112595133177859
https://twitter.com/RealTimeTradez/status/1473809286354583557
https://twitter.com/RealTimeTradez/status/1474081174448398343
πŸ‘οΈ0
forgiveness7x7 forgiveness7x7 3 years ago
ALLK New Patient Dec.21 2021
https://twitter.com/RealTimeTradez/status/1473987872197914633/photo/1
πŸ‘οΈ0
forgiveness7x7 forgiveness7x7 3 years ago
https://twitter.com/SilentTrader93/status/1474112595133177859/photo/1
πŸ‘οΈ0
forgiveness7x7 forgiveness7x7 3 years ago
https://twitter.com/RealTimeTradez/status/1473809286354583557/photo/1
πŸ‘οΈ0
forgiveness7x7 forgiveness7x7 3 years ago
https://twitter.com/RealTimeTradez/status/1474081174448398343/photo/1
πŸ‘οΈ0
forgiveness7x7 forgiveness7x7 3 years ago
https://twitter.com/tryingBot05/status/1473861479309152257/photo/1
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Next week should be sooo good IMO .
πŸ‘οΈ0
Laszlo1 Laszlo1 3 years ago
Took a starter
πŸ‘οΈ0
forgiveness7x7 forgiveness7x7 3 years ago
that's what i'm here scouting out. looks like analysts have different opinions on price. from 10.00 to 60.00
i think it is a short attack and whatever else
πŸ‘οΈ0
Laszlo1 Laszlo1 3 years ago
What happened here what causes the huge drop?
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Huge volume over 63M $$$
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Agree, a little bit more Consolidations, before the next leg up, then BOOOOM .
πŸ‘οΈ0
alchemytrader alchemytrader 3 years ago
10.79
πŸ‘οΈ0
Justfactsmam Justfactsmam 3 years ago
looks like the Short Squeeze commencing!
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Very small SS short squeeze will take it to the moon .
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
I’m good with $50 lol .
πŸ‘οΈ0
sirglenn sirglenn 3 years ago
Maybe they'll buy their own stock. LOL.
πŸ‘οΈ0
Justfactsmam Justfactsmam 3 years ago
And GOLDMAN lowered the price target to $60.00...(6X) from here. Some see things others don't.
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
9.91 > Morgan Stanley Maintains Equal-Weight on Allakos, Lowers Price Target to $10
All these analysts are comedians!
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Expecting $15-$20 next week .
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 3 years ago
Over $10 premarket .
πŸ‘οΈ0
maximumgriff maximumgriff 3 years ago
It’s never too late :)
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock